Once Jin Pharmaceutical Group had completed its equity restructuring, the dust settled.
The company's original shareholders clutched their share transfer agreements, their emotions mixed.
From an emotional standpoint, it was a shame to give up one of the few domestic pharmaceutical companies that insisted on independent research and development.
In particular, Jin Yihong and Lou Musaang's pharmaceutical philosophy, as well as the company's corporate culture, were very appealing.
Chairman Jin Yihong's decisive actions and idealistic beliefs were moving and admirable.
Everyone knew that after today's share buyback, even though Jin Yihong and her supporters had secured absolute control over Jin Pharmaceutical Group, they were now facing stormy seas.
Jin Yihong and her supporters had poured in cold, hard cash, and would most likely be left with nothing.
The stock had already hit its daily limit down today. How long could they last? Tomorrow? The day after?
